CLEARANCE OF CHYLOMICRONS FOLLOWING FISH-OIL AND SEAL OIL FEEDING

被引:32
|
作者
CHRISTENSEN, MS [1 ]
MORTIMER, BC [1 ]
HOY, CE [1 ]
REDGRAVE, TG [1 ]
机构
[1] UNIV WESTERN AUSTRALIA,DEPT PHYSIOL,PERTH,WA,AUSTRALIA
基金
英国医学研究理事会;
关键词
CHYLOMICRONS; CLEARANCE; FISH OIL; SEAL OIL; N-3 POLYUNSATURATED FATTY ACIDS; TRIGLYCERIDE STRUCTURE; RATS;
D O I
10.1016/0271-5317(95)00004-6
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The aim of this study was to examine the effects of n-3 polyunsaturated fatty acids (PUFAs) of different marine origins on the metabolism of chylomicrons following a single ingestion of oil. Two oils both rich in n-3 PUFAs but differing with respect to the intramolecular structure of the triglycerides (TGs) were compared, the first a fish oil with the sn-2 position of TGs enriched with n-3 PUFAs and the second a seal oil with the n-3 PUFAs located in the sn-1/3 positions of the TGs. Radiolabeled rat mesenteric lymph chylomicrons were prepared following intragastric administration of the respective oil in which [H-3]-cholesterol and [C-14]-palmitic acid were dissolved to label the lymph chylomicrons cholesterol and triglycerides, respectively. After intravenous injection of chylomicrons into unanesthetized rats, removal from plasma of radiolabeled cholesterol and palmitate, and uptakes of radiolabels by the liver and spleen were measured. The disappearance of cholesterol label was faster following injection of seal oil chylomicrons compared with fish oil chylomicrons whereas there were no differences in the disappearance of palmitate label. The recovery of palmitate label in the liver after 30 min was significantly higher following injection of fish oil chylomicrons compared with seal oil chylomicrons. Our data demonstrate that the metabolism of chylomicrons is affected by the intramolecular structure of the TG in the dietary oils rich in n-3 PUFAs but the mechanism by which the metabolism is affected is yet unknown.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 50 条
  • [31] IS THERE A ROLE FOR DIETARY FISH-OIL IN THE TREATMENT OF HYPERTENSION
    KENNY, D
    EGAN, BM
    JOURNAL OF HUMAN HYPERTENSION, 1994, 8 (12) : 895 - 905
  • [32] DOES FISH-OIL BENEFIT STONE FORMERS
    ROTHWELL, PJN
    GREEN, R
    BLACKLOCK, NJ
    KAVANAGH, JP
    JOURNAL OF UROLOGY, 1993, 150 (05): : 1391 - 1394
  • [33] CAN WE RECOMMEND FISH-OIL FOR HYPERTENSION
    HOWE, PRC
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (03) : 199 - 203
  • [34] Australian fish-oil quality concerns unfounded
    Paxton, Fay
    JOURNAL OF COMPLEMENTARY MEDICINE, 2007, 6 (04): : 4 - 4
  • [35] The fish-oil CVD biomarker and pregnancy safety
    不详
    JOURNAL OF COMPLEMENTARY MEDICINE, 2008, 7 (01): : 10 - 10
  • [36] EFFECT OF A FISH-OIL FRACTION ON PLASMA LIPIDS
    KINSELL, LW
    WALKER, G
    VISINTINE, RE
    MICHAELS, GD
    DIABETES, 1961, 10 (04) : 316 - &
  • [37] Does fish-oil price equal quality?
    Buttery, Joseph
    JOURNAL OF COMPLEMENTARY MEDICINE, 2007, 6 (02): : 6 - 6
  • [38] OXIDATIVE STABILITY OF FISH-OIL INCLUDED IN A MICROEMULSION
    JAKOBSSON, M
    SIVIK, B
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 1994, 15 (05) : 611 - 619
  • [39] Bioequivalence of encapsulated and microencapsulated fish-oil supplementation
    Barrow, Colin J.
    Nolan, Coleen
    Holub, Bruce J.
    JOURNAL OF FUNCTIONAL FOODS, 2009, 1 (01) : 38 - 43
  • [40] A CONTROLLED TRIAL OF FISH-OIL IN IGA NEPHROPATHY
    DONADIO, JV
    BERGSTRALH, EJ
    OFFORD, KP
    SPENCER, DC
    HOLLEY, KE
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18): : 1194 - 1199